Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies

Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies

© 2018-IOS Press and the authors. All rights reserved. Worldwide there are over 46 million people living with dementia, and this number is expected to double every 20 years reaching about 131 million by 2050. The cost to the community and government health systems, as well as the stress on families...

Full description

Bibliographic Details
Main Authors: Martins, R., Villemagne, V., Sohrabi, H., Chatterjee, P., Shah, T., Verdile, Giuseppe, Fraser, P., Taddei, K., Gupta, V., Rainey-Smith, S., Hone, E., Pedrini, S., Lim, W., Martins, I., Frost, S., Gupta, S., O'Bryant, S., Rembach, A., Ames, D., Ellis, K., Fuller, S., Brown, B., Gardener, S., Fernando, B., Bharadwaj, Prashant, Burnham, S., Laws, S., Barron, A., Goozee, K., Wahjoepramono, E., Asih, P., Doecke, J., Salvado, O., Bush, A., Rowe, C., Gandy, S., Masters, C.
Format: Journal Article
Published: IOS Press 2018
Online Access:http://hdl.handle.net/20.500.11937/67607

Internet

http://hdl.handle.net/20.500.11937/67607

Similar Items